Source: Eur Respir J 2008; 31: 1197-1204
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Woischnik M., Bauer A., Aboutaam R., Pamir A., Stanzel F., de Blic J., Griese M.. Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J 2008; 31: 1197-1204

Member's Comments

No comment yet.

Related content which might interest you: Surfactant proteins in pulmonary alveolar proteinosis in adults Source: Eur Respir J 2004; 24: 426-435 Year: 2004 Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Surfactant dysfunction and alveolar proteinosis Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 Surfactant dysfunction and alveolar proteinosis Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 Surfactant dysfunction and alveolar proteinosis Source: ERS Skills Course 2016 Year: 2016 Surfactant dysfunction and alveolar proteinosis Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Lysosomal iron in pulmonary alveolar proteinosis: a case report Source: Eur Respir J 2009; 33: 673-679 Year: 2009 PAS-negative pulmonary alveolar proteinosis Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Pulmonary alveolar proteinosis due to a novel mutation in CSF2RA Source: Annual Congress 2012 - Paediatric bronchology Year: 2012 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Surfactant proteins in interstitial pneumonia Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases Year: 2005 Pulmonary alveolar proteinosis and GM/CSF antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 Immunolocalization of surfactant protein-a (SP-A) in the lungs of pneumocystis pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009